Clinical Research Of Bushen Shugan Decoction Of Curing Luteal Insufficiency Of Early Menstruation Of Kidney Deficiency-Liver Stagnation

Objective Clinical observation of Kidney Liver Treated luteal insufficiency of menstruation,and provide the basis for clinical application.Materials and Methods In this study, the First Affiliated Hospital of Hunan Medical University obstetrics and gynecology clinic conducted, Case Acquisition Time:January2,2014to August1,2014, included60cases meet the viewing conditions menstruation kidney liver depression syndrome.Using a randomized, single-blind, parallel-group positive drug design methods, subjects were randomly divided into treatment group30cases,30cases in the control group. Subjects before treatment course, there was no significant difference in age and condition. Kidney Liver soup treatment group and control group were given medroxyprogesterone acetate, the10th day of the menstrual cycle, medication, for taking10days, taking a total of three menstrual cycles to complete the total course of treatment. Two days ahead of the menstrual cycle before and after treatment, basic thermometer in high-temperature phase for several days, BBT HPS score,BBT temperature phase sixth day, serum progesterone (P) content, security index changes and medication, adverse effects were observed.Results Treatment group recovered4cases,18cases markedly effective in6cases,2cases, the total efficiency of93.3%; Clinical cure3cases in the control group,11cases markedly effective in8cases,8cases, the total efficiency of73.3%, the clinical efficacy between the two groups was statistically significant difference (P<0.05). Before treatment, the number of days in advance of the menstrual cycle, high-temperature phase for several days, BBT HPS score,BBT temperature phase sixth day, serum progesterone (P) content, clinical symptom score, the difference was not statistically significant (P>0.05), have together with comparability. After treatment, the number of days in the menstrual cycle ahead of the two groups, high-temperature phase for several days, BBT HPS score,BBT temperature phase sixth day, serum progesterone (P) content, clinical symptom scores compared with before treatment was statistically significant (P<0.05), Description both groups advance to shorten the number of days of the menstrual cycle, increasing the number of days to maintain the high-temperature phase, HPS scores increased basal body temperature,increasing the high-temperature phase BBT sixth day, serum progesterone (P) content, and improve clinical symptoms subjects. After treatment, the high temperature phase between BBT sixth day, there was no difference (P>0.05) serum progesterone (P) content, indicating an increase in high-temperature phase BBT sixth day on serum progesterone (P) content was no effect difference. Between the two groups in the shortening of the menstrual cycle in advance the number of days, increase high-temperature phase for several days, HPS scores increased basal body temperature and clinical symptoms was statistically significant (P<0.05), described in the shortening of the menstrual cycle in advance the number of days, HPS scores increased basal body temperature, increase high-temperature phase for several days, and improve the clinical symptom scores in the treatment group effective than the control group.Conclusion Both groups by elevated serum progesterone values for therapeutic purposes, the two groups did not differ on the role of elevated serum progesterone values. However, an increase in the number of days to maintain the high-temperature phase of the menstrual cycle and HPS scores increased basal body temperature,shorten the number of days in advance,the improvement of clinical symptoms, kidney and liver soup taking the treatment group were better than taking medroxyprogesterone acetate in the control group.